Additionally, PLE0 plays a role in regulating epithelial–mesenchymal transition (EMT) by suppressing the expression of type II transforming growth factor beta receptor (TβRII) and the phosphorylation of TβRI in A549 lung cancer cells [15]. The gene discussed is TGFBR2; the disease is lung carcinoma.